APA (7th ed.) Citation

Figueroa Vazquez, V., Ko, J., Breunig, C., Baumann, A., Giesen, N., Palfi, A., . . . Raab, M. (2021). HDP-101, an anti-BCMA antibody-drug conjugate, safely delivers amanitin to induce cell death in proliferating and resting multiple myeloma cells. Molecular cancer therapeutics, 20(2), . https://doi.org/10.1158/1535-7163.MCT-20-0287

Chicago Style (17th ed.) Citation

Figueroa Vazquez, Vianihuini, et al. "HDP-101, an Anti-BCMA Antibody-drug Conjugate, Safely Delivers Amanitin to Induce Cell Death in Proliferating and Resting Multiple Myeloma Cells." Molecular Cancer Therapeutics 20, no. 2 (2021). https://doi.org/10.1158/1535-7163.MCT-20-0287.

MLA (9th ed.) Citation

Figueroa Vazquez, Vianihuini, et al. "HDP-101, an Anti-BCMA Antibody-drug Conjugate, Safely Delivers Amanitin to Induce Cell Death in Proliferating and Resting Multiple Myeloma Cells." Molecular Cancer Therapeutics, vol. 20, no. 2, 2021, https://doi.org/10.1158/1535-7163.MCT-20-0287.